News
02-23-2011, 09:41 PM
Agendia, a world leader in molecular cancer diagnostics, today announced that the company has received its fifth U.S. Food and Drug Administration clearance for MammaPrint, its widely used breast cancer recurrence assay.
More... (http://www.news-medical.net/news/20110223/FDA-clears-Agendias-breast-cancer-recurrence-assay.aspx)
More... (http://www.news-medical.net/news/20110223/FDA-clears-Agendias-breast-cancer-recurrence-assay.aspx)